Trial Profile
A Phase 2, Single Arm, Two Period Study of Sodium Cridanimod in Conjunction With Progestin Therapy in Patients With Endometrial Carcinoma
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 10 Jun 2022
Price :
$35
*
At a glance
- Drugs Cridanimod (Primary) ; Megestrol
- Indications Endometrial cancer
- Focus Therapeutic Use
- Sponsors Xenetic Biosciences
- 18 May 2022 Status changed from completed to discontinued.
- 17 Jul 2020 Status changed from active, no longer recruiting to completed.
- 19 Sep 2018 Status changed from recruiting to active, no longer recruiting.